cardiovascular disease

OXFORD, England and STAMFORD, Conn., August 24, 2026 Caristo Diagnostics announced that new University of Oxford-led research using its...

SEOUL, South Korea, August 24, 2026 Hanmi Pharm announced an exclusive global licensing agreement with Genentech, a member of...

CARLSBAD, California, August 20, 2026 Ionis Pharmaceuticals, Inc. announced that new clinical data supporting its severe hypertriglyceridemia (sHTG) treatment...

BASEL, Switzerland, August 19, 2026 Novartis will present data from 10 abstracts across its cardiovascular portfolio at the 2026...

Boston, Mass. & Liège, Belgium, August 10, 2026 Curium announced the completion of its acquisition of Abscint SA, a...

Chapel Hill, N.C., August 10, 2026 Tenax Therapeutics, Inc. announced topline results from the Phase 3 LEVEL clinical trial...

NEW YORK, August 5, 2026 Lexeo Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative...

SOUTH SAN FRANCISCO, Calif., July 30, 2026 Cytokinetics, Incorporated has achieved a major regulatory and market access milestone for...

THOUSAND OAKS, Calif., July 29, 2026 Amgen has announced that the Committee for Medicinal Products for Human Use (CHMP)...

BAGSVÆRD, Denmark, July 31, 2026 Novo Nordisk announced headline results from the Phase 3 ZEUS cardiovascular outcomes trial evaluating...